at Zacks.com (Wed, 8:46AM)
St. Jude Medical (STJ +0.2%) says data from its catheter study, presented today at the annual scientific meeting of the American Heart Association, showed that it’s EnligHTN renal denervation system provided a significant reduction in office and ambulatory blood pressure measurements at six months. In addition, those treated with the system began experiencing a reduction in blood pressure reduction after just 30 days.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Zacks.com (Tue, 6:10PM)
at Zacks.com (Jan 15, 2015)
at Zacks.com (Jan 8, 2015)
at Nasdaq.com (Dec 29, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs